eFFECTOR Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2021 to Q3 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
eFFECTOR Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q3 2023.
  • eFFECTOR Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2023 was -5.03K %, a 345% decline year-over-year.
  • eFFECTOR Therapeutics, Inc. annual Operating Margin for 2022 was -912 %, a 59.1% increase from 2021.
  • eFFECTOR Therapeutics, Inc. annual Operating Margin for 2021 was -2.23K %, a 6022% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -5.03K -3.9K -345% Jul 1, 2023 Sep 30, 2023
Q2 2023 -2.29K -1K -77.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -996 +1.29K +56.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -912 +1.32K +59.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -1.13K Jul 1, 2022 Sep 30, 2022
Q2 2022 -1.29K Apr 1, 2022 Jun 30, 2022
Q1 2022 -2.29K Jan 1, 2022 Mar 31, 2022
Q4 2021 -2.23K Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.